Can I interrupt and then continue taking Larotrectinib?

Larotrectinib is a highly selective TRK inhibitor, used to treat various types of solid tumors with NTRK gene fusion, and has broad-spectrum anti-tumor activity. This drug prevents the growth and spread of tumor cells by inhibiting the abnormal activation of TRK protein. To achieve optimal efficacy, larotrectinib usually needs to be taken continuously and regularly rather than intermittently.

In general, patients are not advised to discontinue larotrectinib treatment on their own, even if symptoms improve or tumors shrink. Targeted drugs are different from traditional chemotherapy in that they rely on maintaining a certain blood concentration to continuously inhibit tumor-related pathways. Once the drug is stopped at will, it may lead to interruption of treatment, which may lead to rebound proliferation of tumor cells and even the development of drug resistance, affecting the overall treatment effect.

However, in special circumstances, if the patient experiences serious adverse reactions (such as elevated liver enzymes, fatigue, neurological symptoms, etc.), the doctor may recommend temporarily discontinuing the medication or adjusting the dose to ensure medication safety. Such interruptions should be strictly at the discretion of the clinician and should be resumed as soon as possible after side effects have subsided. Studies have shown that some patients may still maintain good efficacy if they continue treatment after short-term interruption of larotrectinib, but only if the timing and duration of the interruption are well controlled.

In summary, interruptions during larotrectinib treatment should be avoided as much as possible. If necessary, it must be carried out under the guidance of a doctor, and changes in the condition before and after the interruption should be closely monitored. Patients should maintain good communication, provide timely feedback on discomfort symptoms, and never stop taking medication without authorization or delay taking medication to ensure that the treatment plan continues to play its intended role.

Reference materials:https://www.drugs.com/